Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Professor Kamila Hawthorne, chairman of the Royal College of GPs, said she had 'serious concerns' about drugs sold by ...

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

While all state Medicaid programs include GLP-1s prescribed for Type 2 diabetes, only 36 states cover at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda).

While all state Medicaid programs include GLP-1s prescribed for Type 2 diabetes, only 36 states cover at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda).

Buy and Sell Gift Cards on eBay eBay is another option for buying and selling gift cards. The bonus here is that buyers and sellers are protected by eBay’s policies, in case something goes wrong ...

Biocon stock price today: Shares of Kiran Mazumdar Shaw-led Biocon extended gains to settle five per cent higher on Tuesday, December 24, after the United States Food and Drug Administration ...

But investors were yesterday disappointed with the results of a trial for its next weight loss drug – a combination of Wegovy and another of its drugs, Saxenda. Novo Nordisk had been hoping ...

On the other hand, Saxenda is currently unavailable for the long term, but you can still access its active ingredient, liraglutide, through the NHS for weight loss. Like Wegovy, you'll need a ...